corrected patient cells / Sernova Biotherapeutics - LARVOL DELTA

AgeX Therapeutics and Sernova to collaborate to engineer universal locally immune protected cell therapies for type I diabetes and hemophilia A (Businesswire) - "AgeX Therapeutics, Inc....and Sernova Corp....announced today a research collaboration where Sernova will utilize AgeX’s UniverCyteTM gene technology to generate immune-protected universal therapeutic cells for use in combination with Sernova’s Cell PouchTM for the treatment of type I diabetes and hemophilia A. The goal is to eliminate the need for immunosuppressive medications following Cell Pouch cell transplantation....Pluripotent stem cell-derived or adult donor-derived human Factor VIII-releasing cells modified with AgeX’s UniverCyte will be evaluated in Sernova’s hemophilia A program."

Licensing / partnership • Hemophilia

Sernova announces presentation of HemAcure hemophilia program results at 23rd Annual Meeting of the American Society of Gene and Cell Therapy (StockHouse) - "Sernova Corp....is pleased to announce that the Horizon 2020 HemAcure Consortium will present scientific results of the consortium's research...in an oral presentation during the ASGCT 23rd Annual Meeting, which is being held in virtual format May 12-15, 2020. The abstract will be presented on May 15 at 11:30 am EDT."

Preclinical • Hemophilia

Sernova highlights achievements of the HemAcure hemophilia cell therapy program presented at ASGCT (Newswire) - "Sernova Corp....highlights positive results associated with the development of a novel, safe cell therapy approach, including our proprietary Cell Pouch(TM), for the treatment of hemophilia A as presented on May 15, 2020, by the Horizon 2020 HemAcure Consortium at the American Society of Gene and Cell Therapy's 23rd Annual Meeting (ASGCT)....'These promising results of the HemAcure consortium are paving the way for future human clinical testing in hemophilia A patients using Sernova's technologies transplanted with corrected FVIII cells...' "

Preclinical • Hemophilia